From Acute Infectious Myocarditis to Chronic Inflammatory Cardiomyopathy: Pathophysiological Mechanisms, Key Investigations, and Current Treatment Strategies

Acute infectious myocarditis is an inflammatory disease of the myocardium caused by a broad range of infectious agents, including viruses, bacteria, fungi, protozoa, helminths, and spirochetes. Its clinical presentation is highly variable, ranging from asymptomatic or mild self-limiting disease to fulminant heart failure, life-threatening arrhythmias, cardiogenic shock, and sudden cardiac death. Although many patients recover completely, persistent myocardial inflammation, incomplete pathogen clearance, immune-mediated injury, and myocardial fibrosis may lead to adverse ventricular remodelling, persistent ventricular dysfunction, and progression to chronic inflammatory cardiomyopathy or dilated cardiomyopathy. The pathophysiology reflects a complex interaction between direct pathogen-mediated myocardial injury and innate and adaptive immune responses, with the balance between effective pathogen clearance and excessive inflammation being a major determinant of outcome. Diagnosis remains challenging because clinical manifestations and conventional investigations are often nonspecific. A multimodal approach incorporating electrocardiography, cardiac biomarkers, echocardiography, cardiovascular magnetic resonance (CMR), microbiological and molecular investigations, and, in selected patients, endomyocardial biopsy is essential for diagnosis and risk stratification. CMR is particularly valuable for identifying myocardial edema, inflammation, necrosis, and fibrosis, whereas endomyocardial biopsy remains important in selected severe or diagnostically uncertain cases. Treatment is primarily guided by clinical severity and the identified infectious etiology. Management includes supportive heart failure therapy, arrhythmia control, temporary restriction of physical activity, and mechanical circulatory support in severe or fulminant disease. Targeted antimicrobial therapy is essential when a treatable pathogen is identified, while routine empiric antiviral therapy or immunosuppression is not currently supported for most presumed viral myocarditis. Emerging approaches involving molecular diagnostics, immunological profiling, novel biomarkers, targeted modulation of inflammatory pathways, and personalized therapies may improve diagnosis and outcomes. This review summarizes current evidence on the etiology, pathophysiology, clinical presentation, diagnosis, treatment, and progression from infectious myocarditis to chronic inflammatory cardiomyopathy.

Authors

Institutions

Publication Details

Journal
Pathogens
Published
2026-11-19
DOI
https://doi.org/10.3390/pathogens15111217
Primary Topic
Viral Infections and Immunology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Acute Infectious Myocarditis to Chronic Inflammatory Cardiomyopathy: Pathophysiological Mechanisms, Key Investigations, and Current Treatment Strategies

Ioana Boarescu, Paul-Mihai Boarescu, Anca Bosancu
Pathogens
Viral Infections and Immunology Research
article

From Acute Infectious Myocarditis to Chronic Inflammatory Cardiomyopathy: Pathophysiological Mechanisms, Key Investigations, and Current Treatment Strategies

Ioana Boarescu, Paul-Mihai Boarescu, Anca Bosancu
article en

Abstract

Acute infectious myocarditis is an inflammatory disease of the myocardium caused by a broad range of infectious agents, including viruses, bacteria, fungi, protozoa, helminths, and spirochetes. Its clinical presentation is highly variable, ranging from asymptomatic or mild self-limiting disease to fulminant heart failure, life-threatening arrhythmias, cardiogenic shock, and sudden cardiac death. Although many patients recover completely, persistent myocardial inflammation, incomplete pathogen clearance, immune-mediated injury, and myocardial fibrosis may lead to adverse ventricular remodelling, persistent ventricular dysfunction, and progression to chronic inflammatory cardiomyopathy or dilated cardiomyopathy. The pathophysiology reflects a complex interaction between direct pathogen-mediated myocardial injury and innate and adaptive immune responses, with the balance between effective pathogen clearance and excessive inflammation being a major determinant of outcome. Diagnosis remains challenging because clinical manifestations and conventional investigations are often nonspecific. A multimodal approach incorporating electrocardiography, cardiac biomarkers, echocardiography, cardiovascular magnetic resonance (CMR), microbiological and molecular investigations, and, in selected patients, endomyocardial biopsy is essential for diagnosis and risk stratification. CMR is particularly valuable for identifying myocardial edema, inflammation, necrosis, and fibrosis, whereas endomyocardial biopsy remains important in selected severe or diagnostically uncertain cases. Treatment is primarily guided by clinical severity and the identified infectious etiology. Management includes supportive heart failure therapy, arrhythmia control, temporary restriction of physical activity, and mechanical circulatory support in severe or fulminant disease. Targeted antimicrobial therapy is essential when a treatable pathogen is identified, while routine empiric antiviral therapy or immunosuppression is not currently supported for most presumed viral myocarditis. Emerging approaches involving molecular diagnostics, immunological profiling, novel biomarkers, targeted modulation of inflammatory pathways, and personalized therapies may improve diagnosis and outcomes. This review summarizes current evidence on the etiology, pathophysiology, clinical presentation, diagnosis, treatment, and progression from infectious myocarditis to chronic inflammatory cardiomyopathy.

PathogensVol. 15(11)
Ştefan cel Mare University of Suceava (RO)
Viral Infections and Immunology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon